申请人:Arzeno Humberto Bartolome
                            
                            
                                公开号:US20110301171A1
                            
                            
                                公开(公告)日:2011-12-08
                            
                            Compounds of formula I
or pharmaceutically acceptable salts thereof,
wherein R
5
is a group of formula (a) or (b):
and wherein m, n, p, q, X, Y, R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
and R
9
are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity.
                            公式I的化合物或其药用盐,其中R5是公式(a)或(b)的一个基团:其中m、n、p、q、X、Y、R1、R2、R3、R4、R5、R6、R7、R8和R9如本文所定义。本文披露的化合物和组合物可用于调节JNK的活性并治疗与JNK活性相关的疾病。